Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq analysis of HCC and hepatocytes

ABSTRACT: RNA-seq analysis of HCC and hepatocytes

PROVIDER: PRJNA714248 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13959181.fastq.gz	Fastqsanger.gz
	SRR13959182.fastq.gz	Fastqsanger.gz
	SRR13959183.fastq.gz	Fastqsanger.gz
	SRR13959184.fastq.gz	Fastqsanger.gz
	SRR13959185.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 17

Similar Datasets

RNA-Seq Analysis

Project description:RNA-Seq analysis carried out in three different backcrosses based on Iberian breed with Landrace, Pietrain and Duroc breeds

2017-10-31 | PRJEB23068 | EVA

Gene expression profiling of normal mouse hepatocyte, premalignant hepatocytes and fully malignant HCC

Project description:Gene expression was analyzed and compared of normal mouse hepatocyte, premalignant hepatocytes and fully malignant HCC cells. The results provide valuable information about the gene expression alterations during the chronic process of liver cancer development. HCC in age-matched male mice were induced by DEN injection. Normal mouse hepatocyte, premalignant hepatocytes and fully malignant HCC were freshly isolated and RNA extracted.

2013-10-11 | E-GEOD-50431 | biostudies-arrayexpress

RNA-Seq analysis of HCV-related HCC and NBNC-HCC tumor and non-tumor part gene analysis

Project description:RNA-Seq analysis of HCV-related HCC and NBNC-HCC tumor and non-tumor part gene analysis

| PRJNA645428 | ENA

RNA Seq Analysis of mouse primary hepatocytes treated with Neurotropin

Project description:RNA Seq Analysis of mouse primary hepatocytes treated with Neurotropin

| PRJNA546600 | ENA

Label-free proteomic analysis of the HCC secretome and compared the protein profiles of human PLC liver cancer cells with that of human THLE3 hepatocytes secreted in conditioned medium

Project description:To identify potential factors related to the development and progression of HCC, we employed label-free proteomic analysis of the HCC secretome and compared the protein profiles of human PLC liver cancer cells with that of human THLE3 hepatocytes secreted in conditioned medium.

2023-02-15 | PXD033437 | Pride

Bulk transcriptomic analysis of two models of zebrafish beta-catenin-driven HCC

Project description:Up to 41% of hepatocellular carcinomas (HCCs) result from activating mutations in the CTNNB1 gene encoding β-catenin. β-catenin has dual cellular functions as a component of the Wnt signaling pathway and adherens junctions. HCC-associated CTNNB1 mutations stabilize the β-catenin protein, leading to nuclear and/or cytoplasmic localization of β-catenin and downstream activation of Wnt target genes. In patient HCC samples, β-catenin nuclear and cytoplasmic localization are typically patchy, even among HCC with highly active CTNNB1 mutations. The functional and clinical relevance of this heterogeneity in β-catenin activation are not well understood. To define mechanisms of β-catenin-driven HCC initiation, we generated a Cre-lox system that enabled switching on activated β-catenin in 1) a small number of hepatocytes in early development; or 2) the majority of hepatocytes in later development or adulthood. We discovered that switching on activated β-catenin in a subset of larval hepatocytes was sufficient to drive HCC initiation. To determine the role of Wnt/β-catenin signaling heterogeneity later in hepatocarcinogenesis, we performed RNA-seq analysis of zebrafish β-catenin-driven HCC. Ingenuity Pathway Analysis of differentially expressed genes in the Cre-lox HCC model revealed that “Cancer” and “Liver Tumor” categories were significantly altered, indicating transcriptional similarities with human HCC and other vertebrate HCC models. At the single-cell level, 2.9% to 15.2% of hepatocytes from zebrafish β-catenin-driven HCC expressed two or more of the Wnt target genes axin2, mtor, glula, myca, and wif1, indicating focal activation of Wnt signaling in established tumors. Thus, heterogeneous β-catenin activation drives HCC initiation and persists throughout hepatocarcinogenesis.

2019-09-27 | GSE137787 | GEO

RNA-Seq analysis of HCV-related HCC and NBNC-HCC tumor and non-tumor part gene analysis

Project description:We performed RNA-seq analysisfor 2 HCV-HCC and 3 NBNC-HCC tumor and non-tumor regions, total for 10 samples to find the lncRNAs candidates in HCV-related HCC.

2020-07-22 | GSE154211 | GEO

Single-cell transcriptomic analysis of two models of zebrafish beta-catenin-driven HCC

2019-09-27 | GSE137784 | GEO

Aberrantly microRNA profiling in cancerous hepatocytes versus normal primary hepatocytes

Project description:MicroRNAs is a rapidly expanding area expected to change the way in which diseases will be diagnosed, treated and monitored in the future. Hepatocellular carcinoma (HCC) shows a rising incidence with high mortality but lack of effective targeted therapies. We identified the aberrantly expressed miRNAs involved in HCC through the comparison of miRNA expression profiling in cancerous hepatocytes with that in normal primary human hepatocytes and found 37 dysregulated miRNAs in HCC. These aberrantly expressed miRNAs may provide insights into pathogenesis of HCC and thus may be used for diagnosis and therapy. Over the past few years, though several studies have uncovered aberrant miRNA expression profiles in HCC compared with matched nonmalignant tissues, the overlap of deregulated miRNAs from different platforms is limited. To solve this problem, we recommend a method that using primary cancer cells or cancer cell lines and nonmalignant primary cells to identify the specific aberrantly miRNA expression profiles in HCC and even in other types of cancer. Here, we identified the aberrantly expressed miRNAs involved in hepatoma through the comparison of miRNA expression profiling in cancerous hepatocytes with that in normal primary human hepatocytes and 37 dysregulated miRNAs were screened out by 2-fold change with a significant difference (P<0.05). Clustering analysis based on 13 miRNAs whose fold changes were over 15-fold change exhibited significantly differential expression pattern between the cancerous and normal hepatocytes.

2010-12-30 | E-GEOD-20077 | biostudies-arrayexpress

RNA-seq of human hepatocellular carcinoma (HCC) patients

Project description:RNA-seq of human hepatocellular carcinoma (HCC) patients

| PRJEB37650 | ENA